Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Laboratory

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.7754/CLIN.LAB.2012.120810PMID 24273921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of CXCL12 (SDF-1α) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran

  2012cited by this paper
• Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications

  2011cited by this paper
• Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

  2010cited by this paper
• Assessment of CXCL12 (SDF-1α) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran.

  2010cited by this paper
• The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes

  2010influential reference
• Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

  2009cited by this paper
• Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

  2009cited by this paper
• Effect of nicotinamide on early graft failure following intraportal islet transplantation

  2009cited by this paper
• Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes

  2008cited by this paper
• Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients

  2008cited by this paper
• Expression of stromal derived factor alpha (SDF-1 alpha) by primary hepatocytes following isolation and heat shock stimulation.

  2008cited by this paper
• Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications

  2007cited by this paper
• Expression of CXC chemokine IP-10/Mob-1 by primary hepatocytes following heat shock.

  2007cited by this paper
• Expression of IP-10 chemokine is regulated by pro-inflammatory cytokines in cultured hepatocytes.

  2007cited by this paper
• Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.

  2007cited by this paper
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• Incidence and trends of Childhood Type 1 diabetes worldwide 1990-1999

  2006cited by this paper
• Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes

  2006cited by this paper
• Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.

  2006cited by this paper
• Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat1

  2006cited by this paper
• Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.

  2006cited by this paper
• Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999

  2006cited by this paper
• Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus

  2006cited by this paper
• Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response?

  2005cited by this paper
• Activation of peripheral blood CD14+ monocytes occurs in diabetes.

  2005cited by this paper
• Preferential transmission and association of the −403 G → A promoter RANTES polymorphism with atopic asthma

  2005cited by this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cited by this paper
• Chemokine Secretion of Rheumatoid Arthritis Synovial Fibroblasts Stimulated by Toll-Like Receptor 2 Ligands1

  2004cited by this paper
• Involvement of Eotaxin, Eosinophils, and Pancreatic Predisposition in Development of Type 1 Diabetes Mellitus in the BioBreeding Rat1

  2004cited by this paper
• Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus

  2003cited by this paper
• Chemokines: attractive mediators of the immune response.

  2003cited by this paper
• Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes.

  2002cited by this paper
• Chemokines and disease

  2001cited by this paper
• Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population.

  2001cited by this paper
• Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.

  2001cited by this paper
• Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1

  2000cited by this paper
• Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes1

  2000cited by this paper
• Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

  2000cited by this paper
• Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes.

  1999cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro.

  1996cited by this paper
• Activation of dual T cell signaling pathways by the chemokine RANTES.

  1995cited by this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cited by this paper

• Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

  2025cites this paper
• Stromal-derived factor-1: The glycoprotein fueling autoimmune storms via CXCR4 and CXCR7.

  2025cites this paper
• Multi-omics investigation of prospective therapeutic targets for type 1 diabetes

  2025cites this paper
• A Composite Biomarker Signature of Type 1 Diabetes Risk Identified via Augmentation of Parallel Multi-Omics Data from a Small Cohort

  2024cites this paper
• A Missing Puzzle in Preclinical Studies—Are CCR2, CCR5, and Their Ligands’ Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?—Evidence from Rodent Models and Clinical Studies

  2024influential citation
• Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity

  2024cites this paper
• A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model

  2024cites this paper
• Investigation of the Correlation Between the Polymorphism/Expression Level of RANTES and Its Receptor CCR5 Gene Promoter and Type 2 Diabetes Mellitus

  2023cites this paper
• Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.

  2023cites this paper
• Screening of the Key Genes and Signaling Pathways for Schizophrenia Using Bioinformatics and Next Generation Sequencing Data Analysis

  2023cites this paper
• Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability

  2023cites this paper
• T cells and their products in diabetic kidney disease

  2023cites this paper
• ACADL Promotes the Differentiation of Goat Intramuscular Adipocytes

  2023cites this paper
• Chemokine CCL2 and Its Receptor CCR2 in Regulation of Cognitive Functions and in Development of Aging Diseases

  2022cites this paper
• Chemokines in Type 1 Diabetes Mellitus

  2022cites this paper
• The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses

  2022cites this paper
• Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets

  2022cites this paper
• Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic

  2022cites this paper
• Syntaxin 4 Enrichment in β-Cells Prevents Conversion to Autoimmune Diabetes in Non-Obese Diabetic (NOD) Mice

  2021cites this paper
• The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review

  2021cites this paper
• Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach

  2021cites this paper
• Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells

  2021cites this paper
• Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis

  2021cites this paper
• Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?

  2020cites this paper
• Genes and transcription factors related to the adverse effects of maternal type I diabetes mellitus on fetal development.

  2019cites this paper
• Serum concentration of angiogenic (CXCL1, CXCL12) and angiostasis (CXCL9, CXCL10) CXC chemokines are differentially altered in normal and gestational diabetes mellitus associated pregnancies

  2019cites this paper
• CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.

  2019cites this paper
• Elevated serum RANTES chemokine levels in autoimmune Addison disease.

  2018cites this paper
• CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy

  2018cites this paper
• Genetic variation, biological structure, sources, and fundamental parts played by CXCL12 in pathophysiology of type 1 diabetes mellitus

  2017cites this paper
• CCL2, CCL5, IL4 and IL15 Gene Polymorphisms in Women with Gestational Diabetes Mellitus

  2016cites this paper
• Identification of novel proliferative diabetic retinopathy related genes on protein-protein interaction network

  2016cites this paper
• Studies of Enterovirus Infection and Induction of Innate Immunity in Human Pancreatic Cells

  2016cites this paper
• Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 Diabetes

  2015cites this paper
• RNA-seq methods for identifying differentially expressed gene in human pancreatic islet cells treated with pro-inflammatory cytokines

  2014cites this paper
• Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris.

  2014cites this paper
• Acta Universitatis Upsaliensis Uppsala 2016

  year unknowncites this paper